Also, these limits, which can be completed with blockchain advancement, may be important for ensuring the advantages of data subjects as portrayed by the EU General Data Protection Regulation. Taking into account the normal size and affectability of clinical data, it is all around acknowledged that the name information of clinical data, not clinical data itself, will be taken care of in data blocks. Regardless, some huge information, similar to information on drug sensitivities, can be circulated in a public blockchain..